Key result
Cardiac resynchronization therapy improved the mean KCCQ score by 20.8 points at 12 months, with baseline QRS area strongly predicting a positive clinical response (OR 4.26).
Why the study?
Patients with heart failure and LBBB experience better outcomes and quality of life after CRT, and various electrocardiographic and clinical parameters may predict this improvement.
Does cardiac resynchronization therapy (CRT) improve Kansas City Cardiomyopathy Questionnaire (KCCQ) scores in patients with symptomatic heart failure, low EF, and LBBB?
Observational (n=69)
No
Does cardiac resynchronization therapy (CRT) improve Kansas City Cardiomyopathy Questionnaire (KCCQ) scores in patients with symptomatic heart failure, low EF, and LBBB?
Effect estimate: mean improvement of 20.8 points
p-value: p=<0.01
CRT produces substantial and sustained improvements in patient-reported quality of life, which can be reliably predicted by baseline and post-procedural electrocardiographic markers such as QRS area and Q-LV interval.
BACKGROUND: Cardiac resynchronization therapy (CRT) is an essential treatment for patients with symptomatic heart failure and ventricular conduction abnormalities. Low-ejection-fraction (EF) cardiomyopathy often involves a wide QRS complex displaying a left bundle branch block (LBBB) morphology and markedly delayed activation of the LV lateral wall. Following CRT, patients with heart failure and LBBB have better outcomes and quality-of-life improvements. Various electrocardiographic and clinical parameters are thought to be able to predict this improvement. The Kansas City Cardiomyopathy Questionnaire (KCCQ) is a reliable tool for measuring these patients' quality of life. METHODS: This is an observational prospective study featuring over 69 individuals diagnosed with cardiac failure and dilatative cardiomyopathy with low-EF and major LBBB. This study analyzed the correlations between patient outcomes and demographic, clinical, and electrocardiographic parameters. RESULTS: Following the analysis, we observed correlations between the QRS area, intraprocedural systolic blood pressure, Q-LV interval, the R-wave amplitude in the right precordial leads and the CRT outcomes indicated by the KCCQ score. CONCLUSIONS: The parameters found and their correlation with the KCCQ score show how CRT therapy impacts patients' quality of life, symptom burden, and functional status.
No takes yet. Share an insight, caveat, or question.
Rosu et al. (2024) conducted an observational in Heart failure and dilatative cardiomyopathy with low-EF and major LBBB (n=69). Cardiac resynchronization therapy (CRT) was evaluated on Change in total Kansas City Cardiomyopathy Questionnaire (KCCQ) score from baseline to 12 months (mean improvement of 20.8 points, p=<0.01). Cardiac resynchronization therapy improved the mean KCCQ score by 20.8 points at 12 months, with baseline QRS area strongly predicting a positive clinical response (OR 4.26).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: